Signal2026-03-19
ClinicalTrials.gov

[NA] Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

Part of

Early Phase Precision Therapeutics

Open primary sourceSee the whole picture